Summary
This project aims at developing an innovative and commercially competitive production platform for high value products as Astaxanthin and Omega-3, to be used for human nutrition or aquaculture.
Astaxanthin is a pigment primary produced by microalgae: this carotenoid has a strong antioxidant power and it is used in different fields as healthcare, food/feed supplementation and as pigmenting agent in aquaculture. However, cultivation of the main microalgae species producing Astaxanthin is costly due to low biomass productivity or low Astaxanthin content, causing an extremely high price of this molecule on the market.
Marine microalgae are also the primary producers of Omega-3, very long chain fatty acids, essential components of high quality diets for humans, being related to cardiovascular wellness, and proper visual and cognitive development. However, due to the high cost of microalgae cultivation, the market of Omega-3 is mostly based on fish or krill oils, with high costs and environment impacts associated.
New sources of Astaxanthin and Omega-3 must thus be implemented: based on the results obtained in ERC-Stg-SOLENALGAE, an innovative, low cost and high productive strategy can be proposed for simultaneous Astaxanthin and Omega-3 production in the robust and fast growing marine microalgae species Nannochloropsis gaditana.
The main objectives of the ASTAOMEGA project will be:
1. To validate to a demonstration stage the ASTAOMEGA system
2. The assessment of the market size and market requirements, through extensive market analysis
3. The identification of the best suitable commercial route to be undertaken to take the ASTAOMEGA system to the market, as inception of a spin-off company and/or the licensing agreements on the IPR exploitation with the interested end-users (see LOIs).
The ASTAOMEGA team is confident that the outcomes of this project are poised to exert a beneficial impact on the European microalgae industry and nutraceuticals market
Astaxanthin is a pigment primary produced by microalgae: this carotenoid has a strong antioxidant power and it is used in different fields as healthcare, food/feed supplementation and as pigmenting agent in aquaculture. However, cultivation of the main microalgae species producing Astaxanthin is costly due to low biomass productivity or low Astaxanthin content, causing an extremely high price of this molecule on the market.
Marine microalgae are also the primary producers of Omega-3, very long chain fatty acids, essential components of high quality diets for humans, being related to cardiovascular wellness, and proper visual and cognitive development. However, due to the high cost of microalgae cultivation, the market of Omega-3 is mostly based on fish or krill oils, with high costs and environment impacts associated.
New sources of Astaxanthin and Omega-3 must thus be implemented: based on the results obtained in ERC-Stg-SOLENALGAE, an innovative, low cost and high productive strategy can be proposed for simultaneous Astaxanthin and Omega-3 production in the robust and fast growing marine microalgae species Nannochloropsis gaditana.
The main objectives of the ASTAOMEGA project will be:
1. To validate to a demonstration stage the ASTAOMEGA system
2. The assessment of the market size and market requirements, through extensive market analysis
3. The identification of the best suitable commercial route to be undertaken to take the ASTAOMEGA system to the market, as inception of a spin-off company and/or the licensing agreements on the IPR exploitation with the interested end-users (see LOIs).
The ASTAOMEGA team is confident that the outcomes of this project are poised to exert a beneficial impact on the European microalgae industry and nutraceuticals market
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/825936 |
| Start date: | 01-09-2018 |
| End date: | 29-02-2020 |
| Total budget - Public funding: | 149 995,00 Euro - 149 955,00 Euro |
Cordis data
Original description
This project aims at developing an innovative and commercially competitive production platform for high value products as Astaxanthin and Omega-3, to be used for human nutrition or aquaculture.Astaxanthin is a pigment primary produced by microalgae: this carotenoid has a strong antioxidant power and it is used in different fields as healthcare, food/feed supplementation and as pigmenting agent in aquaculture. However, cultivation of the main microalgae species producing Astaxanthin is costly due to low biomass productivity or low Astaxanthin content, causing an extremely high price of this molecule on the market.
Marine microalgae are also the primary producers of Omega-3, very long chain fatty acids, essential components of high quality diets for humans, being related to cardiovascular wellness, and proper visual and cognitive development. However, due to the high cost of microalgae cultivation, the market of Omega-3 is mostly based on fish or krill oils, with high costs and environment impacts associated.
New sources of Astaxanthin and Omega-3 must thus be implemented: based on the results obtained in ERC-Stg-SOLENALGAE, an innovative, low cost and high productive strategy can be proposed for simultaneous Astaxanthin and Omega-3 production in the robust and fast growing marine microalgae species Nannochloropsis gaditana.
The main objectives of the ASTAOMEGA project will be:
1. To validate to a demonstration stage the ASTAOMEGA system
2. The assessment of the market size and market requirements, through extensive market analysis
3. The identification of the best suitable commercial route to be undertaken to take the ASTAOMEGA system to the market, as inception of a spin-off company and/or the licensing agreements on the IPR exploitation with the interested end-users (see LOIs).
The ASTAOMEGA team is confident that the outcomes of this project are poised to exert a beneficial impact on the European microalgae industry and nutraceuticals market
Status
CLOSEDCall topic
ERC-2018-PoCUpdate Date
27-04-2024
Images
No images available.
Geographical location(s)
